Alpha-gal - Open Access .click

Results 111 to 120 of about 948,383 (242)

Alpha-gal syndrome [Vietnamese]Publication date from document properties.Alpha-gal-syndrome_general-audience_cleared_VIETNAMESE-P ...

core

Biomaterials for modulating cellular responses of endogenous tendon stem/progenitor cells: A promising avenue for tendon regeneration

BMEMat, EarlyView.
This review comprehensively summarizes emerging biomaterial‐based strategies and underlying mechanisms for modulating endogenous tendon stem/progenitor cells (TSPCs). It offers the most recent insights into TSPC physiology and potential applications of tissue engineering and regenerative medicine in tendons.
Zeyu Zhu +9 more
wiley +1 more source

Alpha-gal syndrome [French]

Alpha-gal syndrome [French]Publication date from document properties.Alpha-gal-syndrome_general-audience_cleared_FRENCH-P ...

core

When alpha-gal hides: A case series of atypical presentations of alpha-gal syndrome in children

Background Alpha-gal syndrome is an IgE-mediated allergy resulting from sensitisation to galactose-alpha-1,3-galactose (alpha-gal). Although classically associated with delayed urticaria or anaphylaxis following red meat ingestion, it ...
Nadisha Badanasinghe +2 more
core +1 more source

Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1

BMEMat, EarlyView.
NP‐SF, designed to target macrophage Dectin‐1 and activated platelets, selectively accumulated in ischemic myocardium, where it was taken up by macrophages after platelet hitchhiking. By inhibiting NLRC5‐related PANoptosis, NP‐SF significantly attenuated pathological damage, and effectively preserved cardiac function in a murine ischemia–reperfusion ...
Guanye Yu +13 more
wiley +1 more source

Alpha-gal syndrome [Arabic]

Alpha-gal syndrome [Arabic]Publication date from document properties.Alpha-gal-syndrome_general-audience_cleared_ARABIC-P ...

core

From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy

BMEMat, EarlyView.
Engineered bacteria serve as smart, living therapeutics that target tumors, deliver drugs, and remodel immunosuppressive microenvironments. This review highlights their potential to potentiate immunotherapy, radiotherapy, and chemotherapy, offering a promising paradigm for precise and synergistic cancer treatment. Abstract The dynamic interplay between
Haonan Shen +9 more
wiley +1 more source

Anti-alpha-Gal antibodies to predict nosocomial pneumonia

Инфекция и иммунитет
Unlike most other mammals, humans have lost the ability to express alpha-1.3-galactosyltransferase (α1.3GT) due to mutations in the GGTA1 gene thereby underlying inability of human cells to synthesize Gala1–3Galb1–4GlcNAc-terminated glycans (αGal), also ...
Vladimir M. Pisarev +5 more
doaj +1 more source

Alpha-Gal detectors in xenotransplantation research: a word of caution.

, 2012
Xenogeneic tissues are currently employed in clinical practice to create biological substitutes (bioprosthetic heart valves) and in the repair of various damaged tissues (pericardium, gastric-mucosa, nerves, cartilage).
Naso F +4 more
core +1 more source

Asymmetric Relationships Between Sustainability Performance, Disclosure, and Market Value Under Isomorphic Disclosure Pressures: Evidence From Japan

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines how sustainability performance is translated into sustainability disclosure under peer‐based isomorphic pressures and how such disclosures are valued in capital markets. Using 2016–2023 panel data from 647 Japanese‐listed firms, we analyze the triadic relationship between sustainability performance, sustainability ...
Kimitaka Nishitani +5 more
wiley +1 more source

alpha-gal syndrome
allergy
red meat allergy

tick
amblyomma americanum
food allergy

ige
case report
immunologic diseases